100 related articles for article (PubMed ID: 25101551)
1. Response by Eric Suba to Sankaranarayanan et al.
Suba EJ
Indian J Med Ethics; 2014; 11(3):178-80. PubMed ID: 25101551
[TBL] [Abstract][Full Text] [Related]
2. Response to article titled "US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns" by Eric J Suba.
Sankaranarayanan R; Nene BM; Shastri S; Esmy PE; Rajkumar R; Muwonge R; Swaminathan R; Malvi SG; Kane S; Desai S; Kelkar R; Hingmire S; Jayant K
Indian J Med Ethics; 2014; 11(3):175-8. PubMed ID: 25101550
[TBL] [Abstract][Full Text] [Related]
3. US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns.
Suba EJ
Indian J Med Ethics; 2014; 11(3):167-75. PubMed ID: 25101547
[TBL] [Abstract][Full Text] [Related]
4. Effect of cervical cancer screening in Scandinavia.
Day NE
Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
[TBL] [Abstract][Full Text] [Related]
5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
6. Effect of a mass screening program on the risk of cervical cancer.
Louhivuori K
Cancer Detect Prev; 1991; 15(6):471-5. PubMed ID: 1782637
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer in Croatia: state of the art and possibilities for prevention.
Znaor A; Strnad M
Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503
[TBL] [Abstract][Full Text] [Related]
8. Assessing capabilities in India today and the role of "outside" opinions.
Jayaram G; Dewar R; Raman R; Rajendiran S; Parkash V
Indian J Med Ethics; 2014; 11(4):1-2. PubMed ID: 25377030
[No Abstract] [Full Text] [Related]
9. Impact of a federally funded cervical cancer screening program on reducing mortality in New Jersey.
Miller ER; Miller A
Prog Clin Biol Res; 1984; 156():313-28. PubMed ID: 6473441
[No Abstract] [Full Text] [Related]
10. "Informing" and "consenting": ethical concerns regarding illiterate and vulnerable participants in clinical trials.
Dewar R; Parkash V; Forrow L
Indian J Med Ethics; 2014; 11(4):1-2. PubMed ID: 25377029
[No Abstract] [Full Text] [Related]
11. [Screening for cervical cancer in women older than 65 years will probably reduce the incidence and mortality].
Hammer A; Fuglsang K; Høgsbjerg K; Blaakær J
Ugeskr Laeger; 2015 Jun; 177(23):V12140697. PubMed ID: 26058436
[TBL] [Abstract][Full Text] [Related]
12. [Outcome and future of mass screening for uterine cervical cancer].
Noda K; Tejima K
Gan No Rinsho; 1983 May; 29(6):483-7. PubMed ID: 6410103
[TBL] [Abstract][Full Text] [Related]
13. High-risk groups and cervical cancer.
Br Med J; 1980 Sep; 281(6241):629-30. PubMed ID: 7437742
[No Abstract] [Full Text] [Related]
14. [Progress in the early detection of cervix cancer from the viewpoint of the Saarland cancer register].
Brenner H; Wiebelt H; Ziegler H
Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):304-9. PubMed ID: 2358181
[TBL] [Abstract][Full Text] [Related]
15. Is cervical cancer screening necessary or the "Paradox" example of Bulgaria.
Kostova P; Zlatkov V
J BUON; 2010; 15(3):556-60. PubMed ID: 20941827
[TBL] [Abstract][Full Text] [Related]
16. Cervical screening: what is the point?
Sasieni P
Lancet; 1995 Jul; 346(8969):244; author reply 246-7. PubMed ID: 7616810
[No Abstract] [Full Text] [Related]
17. Effectiveness of a cancer control programme.
Knox EG; Woodman CB
Cancer Surv; 1988; 7(3):379-401. PubMed ID: 3242791
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of cervical-cancer screening in developing countries.
Suba EJ; Frable WJ; Raab SS
N Engl J Med; 2006 Apr; 354(14):1535-6; author reply 1535-6. PubMed ID: 16598056
[No Abstract] [Full Text] [Related]
19. [Cancer of the cervix uteri: analysis of the cost-benefit and efficacy of opportunistic screening versus organized screening].
Castronovo V; Foidart JM; Boniver J
Rev Med Liege; 1998 May; 53(5):305-7. PubMed ID: 9689888
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer.
Beral V; Hermon C; Muñoz N; Devesa SS
Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
